Fresh Tracks Therapeutics, Inc. Stock

Equities

FRTX

US10802T2042

Biotechnology & Medical Research

Market Closed - OTC Markets Other stock markets 01:52:19 2024-04-25 pm EDT			5-day change	1st Jan Change
0.9206 ^USD	-1.01%		+1.16%	+4.72%

Mar. 15	Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Fresh Tracks Therapeutics, Inc.(OTCPK:FRTX) dropped from S&P TMI Index	CI

Financials (USD)

Sales 2022	6.94M	Sales 2023	8.01M	Capitalization	5.25M
Net income 2022	-21M	Net income 2023	-5M	EV / Sales 2022	-0.59 x
Net cash position 2022	8.63M	Net cash position 2023	10.87M	EV / Sales 2023	-0.7 x
P/E ratio 2022	-0.2 x	P/E ratio 2023	-0.83 x	Employees	4
Yield 2022 *	-	Yield 2023	-	Free-Float	98.4%

More Fundamentals * Assessed data

Chart Fresh Tracks Therapeutics, Inc.

Duration

Period

Style

Dynamic Chart

Latest news about Fresh Tracks Therapeutics, Inc.

Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 15	CI
Fresh Tracks Therapeutics, Inc.(OTCPK:FRTX) dropped from S&P TMI Index	Dec. 21	CI
Fresh Tracks Therapeutics, Inc.(OTCPK:FRTX) dropped from NASDAQ Composite Index	Dec. 18	CI
Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Wall Street Set to Open Wednesday Trading Higher as Investors Await Fed Decision on Interest Rates	23-09-20	MT
US Futures Rise Modestly Pre-Bell as Investors Await Fed Rate Decision	23-09-20	MT
Top Premarket Gainers	23-09-20	MT
Fresh Tracks Therapeutics' Board Approves Liquidation Plan; Shares Rise After Hours	23-09-19	MT
Fresh Tracks Therapeutics, Inc. Announces Chief Executive Officer Changes	23-09-19	CI
Fresh Tracks Therapeutics, Inc. Announces Executive Changes	23-09-19	CI
Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
Fresh Tracks Therapeutics, Inc. Announces Resignation of Robert B. Brown from the Board of Directors, Effective Immediately	23-07-25	CI
Wall Street Set to Open Higher, Investors Look to End Week on Positive Note	23-07-21	MT
Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
Earnings Flash (BBI) FRESH TRACKS THERAPEUTICS Posts Q1 Revenue $9,000	23-05-10	MT

More news

Analyst Recommendations on Fresh Tracks Therapeutics, Inc.

Wall Street Set to Open Wednesday Trading Higher as Investors Await Fed Decision on Interest Rates	23-09-20	MT
US Futures Rise Modestly Pre-Bell as Investors Await Fed Rate Decision	23-09-20	MT
Oppenheimer Adjusts Fresh Tracks Therapeutics Price Target to $4 From $9, Maintains Outperform Rating	22-11-14	MT
Oppenheimer Adjusts Price Target on Fresh Tracks Therapeutics to $9 From $1, Maintains Outperform Rating	22-09-27	MT
HC Wainwright Adjusts Brickell Biotech's Price Target to $4.50 From $2, Keeps Buy Rating	22-08-16	MT

More recommendations

Press releases Fresh Tracks Therapeutics, Inc.

Fresh Tracks Therapeutics : Termination of Material Agreement - Form 8-K	Mar. 07	PU
Fresh Tracks Therapeutics Urges Stockholders to Vote at the Upcoming Special Meeting on February 15th	Feb. 14	AQ
Fresh Tracks Therapeutics Announces Plan to Hold New Special Meeting of Stockholders on February 15th	Dec. 27	AQ
Fresh Tracks Therapeutics Announces Listing on OTC Pink Market	Dec. 19	AQ
Fresh Tracks Therapeutics Announces its Common Stock will be Suspended from Trading on Nasdaq at Open of Business on December 19th	Dec. 18	AQ

More press releases

News in other languages on Fresh Tracks Therapeutics, Inc.

MÄRKTE USA/Uneinheitlich - Zinspfad ungewiss	23-03-08
MÄRKTE USA/Uneinheitlich - Zinssorgen bleiben präsent	23-03-08
MÄRKTE USA/Wall Street mit leichter Erholung	23-03-08
MÄRKTE USA/Wall Street stabilisiert nach Vortagesverlusten	23-03-08
MARKT USA/Wall Street stabilisiert nach Vortagesverlusten	23-03-08

More news

Quotes and Performance

1 day	-1.01%
1 week	+1.16%
Current month	+1.78%
1 month	+5.82%
3 months	-6.06%
6 months	+0.08%
Current year	+4.72%

More quotes

Highs and lows

1 week

0.90

0.93

1 month

0.87

0.95

Current year

0.86

1.01

1 year

0.45

1.10

3 years

0.45

49.05

5 years

0.45

225.00

10 years

0.45

225.00

More quotes

Managers and Directors - Fresh Tracks Therapeutics, Inc.

Managers	Title	Age	Since
Albert Marchio CEO	Chief Executive Officer	72	20-11-30
Nancy Seretta CTO	Chief Tech/Sci/R&D Officer	-	15-12-31
Aaron Fox-Collis AUD	Comptroller/Controller/Auditor	-	20-06-30

Members of the board	Title	Age	Since
Albert Marchio CEO	Chief Executive Officer	72	20-11-30

More insiders

Quotes

Date	Price	Change	Volume
24-04-25	0.9206	-1.01%	422
24-04-24	0.93	+2.20%	13,430
24-04-23	0.91	0.00%	510
24-04-22	0.91	+1.08%	17,356
24-04-19	0.9003	-1.07%	18,717

Delayed Quote OTC Markets, April 25, 2024 at 01:52 pm EDT

More quotes

Company Profile

Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.

Sector

Biotechnology & Medical Research

Calendar

2024-05-08 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

	1st Jan change	Capi.
FRESH TRACKS THERAPEUTICS, INC.	+4.72%	5.5M
VERTEX PHARMACEUTICALS INCORPORATED	-2.26%	103B
REGENERON PHARMACEUTICALS, INC.	+1.41%	95.71B
ARGENX SE	+0.79%	22.02B
BIONTECH SE	-17.84%	20.9B
GENMAB A/S	-11.11%	17.85B
WUXI APPTEC CO., LTD.	-42.83%	16.21B
BEIGENE, LTD.	-17.63%	15.52B
NEUROCRINE BIOSCIENCES, INC.	+4.55%	13.86B
SAREPTA THERAPEUTICS, INC.	+32.11%	12.04B

Bio Therapeutic Drugs